Quest Total Stockholder Equity vs Short Long Term Debt Total Analysis

DGX Stock

USD 136.34 1.21 0.88%

Quest Diagnostics financial indicator trend analysis is much more than just breaking down Quest Diagnostics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Quest Diagnostics is a good investment. Please check the relationship between Quest Diagnostics Total Stockholder Equity and its Short Long Term Debt Total accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

Total Stockholder Equity vs Short Long Term Debt Total

Total Stockholder Equity vs Short Long Term Debt Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Quest Diagnostics Total Stockholder Equity account and Short Long Term Debt Total. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Quest Diagnostics' Total Stockholder Equity and Short Long Term Debt Total is 0.93. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Short Long Term Debt Total in the same time period over historical financial statements of Quest Diagnostics Incorporated, assuming nothing else is changed. The correlation between historical values of Quest Diagnostics' Total Stockholder Equity and Short Long Term Debt Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of Quest Diagnostics Incorporated are associated (or correlated) with its Short Long Term Debt Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Long Term Debt Total has no effect on the direction of Total Stockholder Equity i.e., Quest Diagnostics' Total Stockholder Equity and Short Long Term Debt Total go up and down completely randomly.

Correlation Coefficient

0.93

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Short Long Term Debt Total

Most indicators from Quest Diagnostics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Quest Diagnostics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

At this time, Quest Diagnostics' Discontinued Operations is fairly stable compared to the past year. Tax Provision is likely to rise to about 266.4 M in 2024, whereas Selling General Administrative is likely to drop slightly above 1.5 B in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	4.2B	3.4B	3.1B	2.7B
Total Revenue	10.8B	9.9B	9.3B	6.9B

Gross Profit Total Revenue

Quest Diagnostics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Intangible Assets
Total Assets		0.97	0.65	0.87	0.99	0.71	0.91	0.86	0.19	0.61	0.99	0.11	0.61	0.94	0.81	-0.09	0.99	0.84	0.25	-0.79	0.99	0.38	0.87	0.29	0.82	0.92
Short Long Term Debt Total	0.97		0.6	0.91	0.93	0.65	0.95	0.81	0.19	0.59	0.97	0.14	0.59	0.85	0.83	-0.03	0.97	0.75	0.26	-0.77	0.99	0.36	0.81	0.48	0.84	0.9
Other Current Liab	0.65	0.6		0.65	0.65	0.87	0.55	0.82	0.73	0.56	0.63	-0.27	0.56	0.68	0.47	-0.46	0.59	0.7	0.19	-0.73	0.63	0.83	0.62	0.22	0.4	0.66
Total Current Liabilities	0.87	0.91	0.65		0.82	0.66	0.84	0.73	0.22	0.64	0.85	0.11	0.64	0.82	0.71	-0.04	0.83	0.74	0.28	-0.66	0.9	0.38	0.82	0.66	0.7	0.87
Total Stockholder Equity	0.99	0.93	0.65	0.82		0.73	0.86	0.88	0.19	0.61	0.98	0.06	0.61	0.95	0.77	-0.13	0.97	0.86	0.21	-0.8	0.96	0.37	0.87	0.2	0.78	0.91
Property Plant And Equipment Net	0.71	0.65	0.87	0.66	0.73		0.52	0.84	0.65	0.76	0.67	-0.17	0.76	0.76	0.39	-0.58	0.66	0.82	-0.03	-0.71	0.69	0.81	0.77	0.18	0.34	0.63
Net Debt	0.91	0.95	0.55	0.84	0.86	0.52		0.75	0.14	0.33	0.94	0.19	0.33	0.75	0.9	0.07	0.93	0.62	0.39	-0.75	0.94	0.3	0.62	0.45	0.91	0.89
Retained Earnings	0.86	0.81	0.82	0.73	0.88	0.84	0.75		0.48	0.63	0.86	-0.03	0.63	0.82	0.73	-0.2	0.83	0.71	0.17	-0.95	0.83	0.64	0.73	0.22	0.69	0.85
Accounts Payable	0.19	0.19	0.73	0.22	0.19	0.65	0.14	0.48		0.38	0.17	-0.06	0.38	0.2	0.17	-0.51	0.18	0.31	0.17	-0.4	0.2	0.97	0.25	0.08	0.09	0.17
Cash	0.61	0.59	0.56	0.64	0.61	0.76	0.33	0.63	0.38		0.52	-0.04	1.0	0.68	0.26	-0.3	0.55	0.68	-0.18	-0.5	0.59	0.52	0.88	0.32	0.24	0.45
Non Current Assets Total	0.99	0.97	0.63	0.85	0.98	0.67	0.94	0.86	0.17	0.52		0.12	0.52	0.91	0.85	-0.06	0.99	0.79	0.27	-0.81	0.98	0.35	0.8	0.29	0.86	0.93
Non Currrent Assets Other	0.11	0.14	-0.27	0.11	0.06	-0.17	0.19	-0.03	-0.06	-0.04	0.12		-0.04	0.06	0.47	0.63	0.18	-0.01	0.56	0.13	0.17	-0.09	0.07	-0.02	0.49	0.01
Cash And Short Term Investments	0.61	0.59	0.56	0.64	0.61	0.76	0.33	0.63	0.38	1.0	0.52	-0.04		0.68	0.26	-0.3	0.55	0.68	-0.18	-0.5	0.59	0.52	0.88	0.32	0.24	0.45
Net Receivables	0.94	0.85	0.68	0.82	0.95	0.76	0.75	0.82	0.2	0.68	0.91	0.06	0.68		0.68	-0.14	0.9	0.93	0.18	-0.68	0.91	0.38	0.93	0.15	0.68	0.85
Common Stock Total Equity	0.81	0.83	0.47	0.71	0.77	0.39	0.9	0.73	0.17	0.26	0.85	0.47	0.26	0.68		0.37	0.85	0.48	0.57	-0.69	0.84	0.27	0.54	0.29	0.99	0.8
Common Stock Shares Outstanding	-0.09	-0.03	-0.46	-0.04	-0.13	-0.58	0.07	-0.2	-0.51	-0.3	-0.06	0.63	-0.3	-0.14	0.37		-0.03	-0.4	0.39	0.18	-0.04	-0.57	-0.21	0.08	0.39	-0.02
Non Current Liabilities Total	0.99	0.97	0.59	0.83	0.97	0.66	0.93	0.83	0.18	0.55	0.99	0.18	0.55	0.9	0.85	-0.03		0.8	0.27	-0.77	0.99	0.35	0.82	0.26	0.86	0.88
Inventory	0.84	0.75	0.7	0.74	0.86	0.82	0.62	0.71	0.31	0.68	0.79	-0.01	0.68	0.93	0.48	-0.4	0.8		0.1	-0.57	0.81	0.48	0.9	0.08	0.48	0.7
Other Current Assets	0.25	0.26	0.19	0.28	0.21	-0.03	0.39	0.17	0.17	-0.18	0.27	0.56	-0.18	0.18	0.57	0.39	0.27	0.1		-0.1	0.29	0.11	0.1	0.04	0.57	0.22
Other Stockholder Equity	-0.79	-0.77	-0.73	-0.66	-0.8	-0.71	-0.75	-0.95	-0.4	-0.5	-0.81	0.13	-0.5	-0.68	-0.69	0.18	-0.77	-0.57	-0.1		-0.77	-0.54	-0.59	-0.27	-0.66	-0.81
Total Liab	0.99	0.99	0.63	0.9	0.96	0.69	0.94	0.83	0.2	0.59	0.98	0.17	0.59	0.91	0.84	-0.04	0.99	0.81	0.29	-0.77		0.37	0.85	0.38	0.85	0.91
Property Plant And Equipment Gross	0.38	0.36	0.83	0.38	0.37	0.81	0.3	0.64	0.97	0.52	0.35	-0.09	0.52	0.38	0.27	-0.57	0.35	0.48	0.11	-0.54	0.37		0.42	0.15	0.19	0.34
Total Current Assets	0.87	0.81	0.62	0.82	0.87	0.77	0.62	0.73	0.25	0.88	0.8	0.07	0.88	0.93	0.54	-0.21	0.82	0.9	0.1	-0.59	0.85	0.42		0.26	0.54	0.7
Short Term Debt	0.29	0.48	0.22	0.66	0.2	0.18	0.45	0.22	0.08	0.32	0.29	-0.02	0.32	0.15	0.29	0.08	0.26	0.08	0.04	-0.27	0.38	0.15	0.26		0.27	0.41
Common Stock	0.82	0.84	0.4	0.7	0.78	0.34	0.91	0.69	0.09	0.24	0.86	0.49	0.24	0.68	0.99	0.39	0.86	0.48	0.57	-0.66	0.85	0.19	0.54	0.27		0.79
Intangible Assets	0.92	0.9	0.66	0.87	0.91	0.63	0.89	0.85	0.17	0.45	0.93	0.01	0.45	0.85	0.8	-0.02	0.88	0.7	0.22	-0.81	0.91	0.34	0.7	0.41	0.79

Click cells to compare fundamentals

Quest Diagnostics Account Relationship Matchups

Quest Diagnostics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	12.8B	14.0B	13.6B	12.8B	14.0B	8.5B
Short Long Term Debt Total	5.3B	4.7B	4.7B	4.6B	5.4B	3.1B
Other Current Liab	778M	1.2B	1.2B	1.1B	1.5B	1.6B
Total Current Liabilities	2.0B	1.8B	1.8B	1.6B	1.8B	1.2B
Total Stockholder Equity	5.6B	6.8B	6.4B	5.9B	6.3B	3.9B
Property Plant And Equipment Net	2.0B	2.2B	2.3B	2.4B	2.4B	2.5B
Net Debt	4.1B	3.5B	3.8B	4.3B	4.7B	2.7B
Retained Earnings	8.2B	9.3B	7.6B	8.3B	8.8B	9.3B
Accounts Payable	263M	446M	357M	324M	1.4B	1.4B
Cash	1.2B	1.2B	872M	315M	686M	720.3M
Non Current Assets Total	10.4B	11.0B	10.9B	10.9B	11.7B	6.9B
Non Currrent Assets Other	160M	176M	163M	144M	198M	177.5M
Cash And Short Term Investments	1.2B	1.2B	872M	315M	686M	720.3M
Net Receivables	1.1B	1.5B	1.4B	1.2B	1.2B	892.3M
Liabilities And Stockholders Equity	12.8B	14.0B	13.6B	12.8B	14.0B	8.5B
Non Current Liabilities Total	5.1B	5.4B	5.3B	5.3B	5.8B	3.3B
Inventory	123M	223M	208M	192M	190M	104.0M
Other Current Assets	112M	157M	223M	196M	286M	227.8M
Other Stockholder Equity	(2.5B)	(2.5B)	(1.2B)	(2.4B)	(2.5B)	(2.4B)
Total Liab	7.1B	7.1B	7.0B	6.8B	7.6B	4.6B
Property Plant And Equipment Gross	2.0B	2.2B	2.3B	2.4B	5.8B	6.1B
Total Current Assets	2.5B	3.1B	2.7B	1.9B	2.4B	1.6B
Accumulated Other Comprehensive Income	(59M)	(39M)	(21M)	(14M)	14M	14.7M
Short Term Debt	949M	143M	153M	155M	456M	241.5M
Intangible Assets	1.2B	1.1B	1.2B	1.1B	1.2B	968.0M
Other Liab	683M	847M	792M	812M	933.8M	472.6M
Other Assets	64M	1.3B	163M	144M	165.6M	196.9M
Long Term Debt	4.0B	4.0B	4.0B	4.0B	4.4B	3.0B
Property Plant Equipment	1.5B	1.6B	2.3B	2.4B	2.7B	2.8B
Good Will	6.6B	6.9B	7.1B	7.2B	7.7B	5.7B
Treasury Stock	(5.2B)	(5.4B)	(3.5B)	(4.7B)	(4.2B)	(4.4B)
Net Tangible Assets	(1.6B)	(700M)	(1.8B)	(1.9B)	(2.1B)	(2.2B)
Noncontrolling Interest In Consolidated Entity	46M	50M	39M	37M	42.6M	34.3M
Retained Earnings Total Equity	8.2B	9.3B	7.6B	8.3B	9.5B	6.6B

When determining whether Quest Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Quest Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Quest Diagnostics Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Quest Diagnostics Incorporated Stock:

How To Invest In Quest

Details

Is Quest Stock a good investment?

Details

What is Quest Diagnostics' Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

Note that the Quest Diagnostics information on this page should be used as a complementary analysis to other Quest Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for Quest Stock analysis

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.

	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance

Is Quest Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quest Diagnostics. If investors know Quest will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quest Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.03)

Dividend Share

2.88

Earnings Share

7.43

Revenue Per Share

83.105

Quarterly Revenue Growth

0.015

The market value of Quest Diagnostics is measured differently than its book value, which is the value of Quest that is recorded on the company's balance sheet. Investors also form their own opinion of Quest Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Quest Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quest Diagnostics' market value can be influenced by many factors that don't directly affect Quest Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Quest Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Quest Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quest Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Quest Total Stockholder Equity vs Short Long Term Debt Total Analysis

Total Stockholder Equity vs Short Long Term Debt Total

Total Stockholder Equity vs Short Long Term Debt Total Correlation Analysis

Correlation Coefficient

Total Stockholder Equity

Short Long Term Debt Total

Quest Diagnostics fundamental ratios Correlations

Quest Diagnostics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Quest Diagnostics fundamental ratios Accounts

Complementary Tools for Quest Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Stockholder Equity	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Non Current Liabilities Total	+ 0.99	Total Assets
Total Liab	+ 0.99	Total Assets
Total Liab	+ 0.99	Short Long Term Debt Total

Other Stockholder Equity	- 0.95	Retained Earnings
Intangible Assets	- 0.81	Other Stockholder Equity
Other Stockholder Equity	- 0.81	Non Current Assets Total
Other Stockholder Equity	- 0.8	Total Stockholder Equity
Other Stockholder Equity	- 0.79	Total Assets
Total Liab	- 0.77	Other Stockholder Equity